Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antihypertensive Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Diuretics
1.2.3 β-blockers
1.2.4 Calcium Channel Blockers
1.2.5 Renin-angiotensin System Inhibitors
1.3 Market by Application
1.3.1 Global Oral Antihypertensive Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Online Pharmacy
1.3.3 Offline Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antihypertensive Drug Market Perspective (2018-2033)
2.2 Oral Antihypertensive Drug Growth Trends by Region
2.2.1 Global Oral Antihypertensive Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oral Antihypertensive Drug Historic Market Size by Region (2018-2023)
2.2.3 Oral Antihypertensive Drug Forecasted Market Size by Region (2024-2033)
2.3 Oral Antihypertensive Drug Market Dynamics
2.3.1 Oral Antihypertensive Drug Industry Trends
2.3.2 Oral Antihypertensive Drug Market Drivers
2.3.3 Oral Antihypertensive Drug Market Challenges
2.3.4 Oral Antihypertensive Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Antihypertensive Drug Players by Revenue
3.1.1 Global Top Oral Antihypertensive Drug Players by Revenue (2018-2023)
3.1.2 Global Oral Antihypertensive Drug Revenue Market Share by Players (2018-2023)
3.2 Global Oral Antihypertensive Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Antihypertensive Drug Revenue
3.4 Global Oral Antihypertensive Drug Market Concentration Ratio
3.4.1 Global Oral Antihypertensive Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antihypertensive Drug Revenue in 2022
3.5 Oral Antihypertensive Drug Key Players Head office and Area Served
3.6 Key Players Oral Antihypertensive Drug Product Solution and Service
3.7 Date of Enter into Oral Antihypertensive Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antihypertensive Drug Breakdown Data by Type
4.1 Global Oral Antihypertensive Drug Historic Market Size by Type (2018-2023)
4.2 Global Oral Antihypertensive Drug Forecasted Market Size by Type (2024-2033)
5 Oral Antihypertensive Drug Breakdown Data by Application
5.1 Global Oral Antihypertensive Drug Historic Market Size by Application (2018-2023)
5.2 Global Oral Antihypertensive Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oral Antihypertensive Drug Market Size (2018-2033)
6.2 North America Oral Antihypertensive Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Oral Antihypertensive Drug Market Size by Country (2018-2023)
6.4 North America Oral Antihypertensive Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Antihypertensive Drug Market Size (2018-2033)
7.2 Europe Oral Antihypertensive Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Oral Antihypertensive Drug Market Size by Country (2018-2023)
7.4 Europe Oral Antihypertensive Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Antihypertensive Drug Market Size (2018-2033)
8.2 Asia-Pacific Oral Antihypertensive Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Antihypertensive Drug Market Size (2018-2033)
9.2 Latin America Oral Antihypertensive Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Oral Antihypertensive Drug Market Size by Country (2018-2023)
9.4 Latin America Oral Antihypertensive Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Antihypertensive Drug Market Size (2018-2033)
10.2 Middle East & Africa Oral Antihypertensive Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Oral Antihypertensive Drug Introduction
11.1.4 Novartis Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Oral Antihypertensive Drug Introduction
11.2.4 Pfizer Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Oral Antihypertensive Drug Introduction
11.3.4 Johnson & Johnson Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antihypertensive Drug Introduction
11.4.4 Sanofi Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Lupin
11.5.1 Lupin Company Detail
11.5.2 Lupin Business Overview
11.5.3 Lupin Oral Antihypertensive Drug Introduction
11.5.4 Lupin Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.5.5 Lupin Recent Development
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Company Detail
11.6.2 Ranbaxy Laboratories Business Overview
11.6.3 Ranbaxy Laboratories Oral Antihypertensive Drug Introduction
11.6.4 Ranbaxy Laboratories Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.6.5 Ranbaxy Laboratories Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Oral Antihypertensive Drug Introduction
11.7.4 Merck Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Astra Zeneca
11.8.1 Astra Zeneca Company Detail
11.8.2 Astra Zeneca Business Overview
11.8.3 Astra Zeneca Oral Antihypertensive Drug Introduction
11.8.4 Astra Zeneca Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.8.5 Astra Zeneca Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Detail
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Oral Antihypertensive Drug Introduction
11.9.4 Daiichi Sankyo Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.9.5 Daiichi Sankyo Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Oral Antihypertensive Drug Introduction
11.10.4 Takeda Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.10.5 Takeda Recent Development
11.11 Actelion
11.11.1 Actelion Company Detail
11.11.2 Actelion Business Overview
11.11.3 Actelion Oral Antihypertensive Drug Introduction
11.11.4 Actelion Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.11.5 Actelion Recent Development
11.12 United Therapeutics
11.12.1 United Therapeutics Company Detail
11.12.2 United Therapeutics Business Overview
11.12.3 United Therapeutics Oral Antihypertensive Drug Introduction
11.12.4 United Therapeutics Revenue in Oral Antihypertensive Drug Business (2018-2023)
11.12.5 United Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Antihypertensive Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Diuretics
Table 3. Key Players of β-blockers
Table 4. Key Players of Calcium Channel Blockers
Table 5. Key Players of Renin-angiotensin System Inhibitors
Table 6. Global Oral Antihypertensive Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Oral Antihypertensive Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Oral Antihypertensive Drug Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Oral Antihypertensive Drug Market Share by Region (2018-2023)
Table 10. Global Oral Antihypertensive Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Oral Antihypertensive Drug Market Share by Region (2024-2033)
Table 12. Oral Antihypertensive Drug Market Trends
Table 13. Oral Antihypertensive Drug Market Drivers
Table 14. Oral Antihypertensive Drug Market Challenges
Table 15. Oral Antihypertensive Drug Market Restraints
Table 16. Global Oral Antihypertensive Drug Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Oral Antihypertensive Drug Market Share by Players (2018-2023)
Table 18. Global Top Oral Antihypertensive Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antihypertensive Drug as of 2022)
Table 19. Ranking of Global Top Oral Antihypertensive Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Oral Antihypertensive Drug Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oral Antihypertensive Drug Product Solution and Service
Table 23. Date of Enter into Oral Antihypertensive Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Antihypertensive Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Oral Antihypertensive Drug Revenue Market Share by Type (2018-2023)
Table 27. Global Oral Antihypertensive Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Oral Antihypertensive Drug Revenue Market Share by Type (2024-2033)
Table 29. Global Oral Antihypertensive Drug Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Oral Antihypertensive Drug Revenue Market Share by Application (2018-2023)
Table 31. Global Oral Antihypertensive Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Oral Antihypertensive Drug Revenue Market Share by Application (2024-2033)
Table 33. North America Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Oral Antihypertensive Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Oral Antihypertensive Drug Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Oral Antihypertensive Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Oral Antihypertensive Drug Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Oral Antihypertensive Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Oral Antihypertensive Drug Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Oral Antihypertensive Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oral Antihypertensive Drug Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Oral Antihypertensive Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Oral Antihypertensive Drug Market Size by Country (2024-2033) & (US$ Million)
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Oral Antihypertensive Drug Product
Table 51. Novartis Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Oral Antihypertensive Drug Product
Table 56. Pfizer Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Johnson & Johnson Company Detail
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Oral Antihypertensive Drug Product
Table 61. Johnson & Johnson Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. Sanofi Company Detail
Table 64. Sanofi Business Overview
Table 65. Sanofi Oral Antihypertensive Drug Product
Table 66. Sanofi Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Lupin Company Detail
Table 69. Lupin Business Overview
Table 70. Lupin Oral Antihypertensive Drug Product
Table 71. Lupin Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 72. Lupin Recent Development
Table 73. Ranbaxy Laboratories Company Detail
Table 74. Ranbaxy Laboratories Business Overview
Table 75. Ranbaxy Laboratories Oral Antihypertensive Drug Product
Table 76. Ranbaxy Laboratories Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 77. Ranbaxy Laboratories Recent Development
Table 78. Merck Company Detail
Table 79. Merck Business Overview
Table 80. Merck Oral Antihypertensive Drug Product
Table 81. Merck Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Astra Zeneca Company Detail
Table 84. Astra Zeneca Business Overview
Table 85. Astra Zeneca Oral Antihypertensive Drug Product
Table 86. Astra Zeneca Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 87. Astra Zeneca Recent Development
Table 88. Daiichi Sankyo Company Detail
Table 89. Daiichi Sankyo Business Overview
Table 90. Daiichi Sankyo Oral Antihypertensive Drug Product
Table 91. Daiichi Sankyo Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 92. Daiichi Sankyo Recent Development
Table 93. Takeda Company Detail
Table 94. Takeda Business Overview
Table 95. Takeda Oral Antihypertensive Drug Product
Table 96. Takeda Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 97. Takeda Recent Development
Table 98. Actelion Company Detail
Table 99. Actelion Business Overview
Table 100. Actelion Oral Antihypertensive Drug Product
Table 101. Actelion Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 102. Actelion Recent Development
Table 103. United Therapeutics Company Detail
Table 104. United Therapeutics Business Overview
Table 105. United Therapeutics Oral Antihypertensive Drug Product
Table 106. United Therapeutics Revenue in Oral Antihypertensive Drug Business (2018-2023) & (US$ Million)
Table 107. United Therapeutics Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antihypertensive Drug Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Oral Antihypertensive Drug Market Share by Type: 2022 VS 2033
Figure 3. Diuretics Features
Figure 4. β-blockers Features
Figure 5. Calcium Channel Blockers Features
Figure 6. Renin-angiotensin System Inhibitors Features
Figure 7. Global Oral Antihypertensive Drug Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Oral Antihypertensive Drug Market Share by Application: 2022 VS 2033
Figure 9. Online Pharmacy Case Studies
Figure 10. Offline Pharmacy Case Studies
Figure 11. Oral Antihypertensive Drug Report Years Considered
Figure 12. Global Oral Antihypertensive Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Oral Antihypertensive Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Oral Antihypertensive Drug Market Share by Region: 2022 VS 2033
Figure 15. Global Oral Antihypertensive Drug Market Share by Players in 2022
Figure 16. Global Top Oral Antihypertensive Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antihypertensive Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Oral Antihypertensive Drug Revenue in 2022
Figure 18. North America Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Oral Antihypertensive Drug Market Share by Country (2018-2033)
Figure 20. United States Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Oral Antihypertensive Drug Market Share by Country (2018-2033)
Figure 24. Germany Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Oral Antihypertensive Drug Market Share by Region (2018-2033)
Figure 32. China Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Oral Antihypertensive Drug Market Share by Country (2018-2033)
Figure 40. Mexico Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Oral Antihypertensive Drug Market Share by Country (2018-2033)
Figure 44. Turkey Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Oral Antihypertensive Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 49. Sanofi Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 50. Lupin Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 51. Ranbaxy Laboratories Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 52. Merck Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 53. Astra Zeneca Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 54. Daiichi Sankyo Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 55. Takeda Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 56. Actelion Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 57. United Therapeutics Revenue Growth Rate in Oral Antihypertensive Drug Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed